| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |